Fireside Chats have become one of the more popular program elements to our global events. Fireside chats feature candid Q&As between biopharma CEOs, who discuss recent company successes, what keeps the C-suite up at night, and where the industry’s leading companies are headed in 2014.

West Moving East

Tuesday, November 12, 2013
11:00 a.m. - 11:55 a.m.
Room 402 A&B
Moderator: E. Allan Gabor, Managing Director, Merck Serono China

	Susan Herbert, PhD Head of Global BD & Strategy Merck KGaA
	Annalisa Jenkins, MBBS, MRCP Executive VP and Head of Global Research and Development Merck KGaA

New Face of Traditional Medicine

Tuesday, November 12, 2013
3:00 p.m. - 3:55 p.m.
Room 403
Moderator: Helen Chen, Director & Partner, L.E.K. Consulting 

Dr. Henry Sun Vice President, Tasly Holding Group CEO, Tasly Pharmaceuticals, Inc.

Innovation/Dealmaking in China from a Small Company Perspective

Wednesday, November 13, 2013
9:30 a.m. - 10:25 a.m.
Room 405
Moderator: Alan F. Eisenberg, Vice President, Federal Government Relations, Celgene Corp.

Wang Yinxiang, PhD CEO and Chief Scientific Officer Zhejiang Beta Pharma

Additional One-on-One Dialogues

Tuesday, November 12, 2013
1:30 p.m. - 2:25 p.m.
​Room 403
Moderator: C. Simone Fishburn, Senior Editor, SciBX at BioCentury Publications

Wang Xiaodong, PhD Director and Investigator National Institute of Biological Sciences (NIBS)